IL1B and depressive symptom measurement: Fluoxetine, a commonly used antidepressant, has been documented to lower serum levels of inflammatory markers including IL‐1β, IL‐6, and TNF‐α (Mojiri‐Forushani et al., 2023), suggesting that inhibition of inflammation could attenuate depression.